Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Sujata Thakur, Rishika Dhapola, Phulen Sarma, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 1-17
Closed Access | Times Cited: 252
Oxidative Stress in Health and Disease
V. Prakash Reddy
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2925-2925
Open Access | Times Cited: 97
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease
Seigmund Wai Tsuen Lai, Edwin De Jesus Lopez Gonzalez, Tala Zoukari, et al.
Chemical Research in Toxicology (2022) Vol. 35, Iss. 10, pp. 1720-1746
Open Access | Times Cited: 76
The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
Marta Rusek, Joanna Smith, Kamel El-Khatib, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 864-864
Open Access | Times Cited: 64
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
Toshiyuki Oshitari
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2927-2927
Open Access | Times Cited: 41
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 15
Repositioning of baricitinib for management of memory impairment in ovariectomized/D-galactose treated rats: A potential role of JAK2/STAT3-PI3K/AKT/mTOR signaling pathway
Merhan O. Hindam, Lamiaa A. Ahmed, Nesrine S. El Sayed, et al.
Life Sciences (2024) Vol. 351, pp. 122838-122838
Closed Access | Times Cited: 6
To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis
Yuan Li, Yingjie Li, Zhaoqiong Zhu
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions
Sumit Kumar, Sidharth Mehan, Acharan S. Narula
Journal of Molecular Medicine (2022) Vol. 101, Iss. 1-2, pp. 9-49
Closed Access | Times Cited: 19
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 16
NLRP1 inflammasome in neurodegenerative disorders: from pathology to therapies
Miqin Zhang, Long Yang, Zhuo-yao Li, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 3
Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 12
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
Thomas Gabriel Schreiner, Cristina Croitoru, Diana Nicoleta Hodorog, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 2
Zinc finger E-Box binding homeobox 2 (ZEB2)-induced astrogliosis protected neuron from pyroptosis in cerebral ischemia and reperfusion injury
Zhixin Zhao, Xiaoming Hu, Jie Wang, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12917-12930
Open Access | Times Cited: 11
Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer
Weikang Kong, Lingxia Zhu, Tian Li, et al.
European Journal of Pharmacology (2023) Vol. 948, pp. 175703-175703
Closed Access | Times Cited: 4
Emerging paradigms in Alzheimer's therapy
Agnes Preethy H., Kayalvizhi Rajendran, Anitha Josephine Sukumar, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176872-176872
Closed Access | Times Cited: 1
Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer’s diseases
Sarangthem Dinamani Singh, Pankaj Bharali, Selvaraman Nagamani
Molecular Diversity (2024)
Closed Access | Times Cited: 1
From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies
Mădălina Georgeta Sighencea, R. Popescu, Simona Trifu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12311-12311
Open Access | Times Cited: 1
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Staley A. Brod
Journal of Alzheimer s Disease (2021) Vol. 85, Iss. 2, pp. 457-472
Closed Access | Times Cited: 9
Ginsenoside Rg1 attenuates LPS-induced cognitive impairments and neuroinflammation by inhibiting NOX2 and Ca2+–CN–NFAT1 signaling in mice
Xianan Dong, Lan Li, Duoduo Zhang, et al.
Journal of Functional Foods (2021) Vol. 87, pp. 104791-104791
Open Access | Times Cited: 8
Sentinels of neuroinflammation: the crucial role of myeloid cells in the pathogenesis of gliomas and neurodegenerative diseases
Blanca Cómitre-Mariano, Gabriel Vellila-Alonso, Berta Segura‐Collar, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access
Pharmacotherapy for Alzheimer’s disease: what’s new on the horizon?
Rita Khoury, Amy Gallop, Kelsey Roberts, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 11, pp. 1305-1323
Closed Access | Times Cited: 2
Page 1

Scroll to top